A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Nutrient formulae
- Indications Diabetic nephropathies; Peripheral neuropathies
- Focus Biomarker; Therapeutic Use
- 30 Aug 2013 Biomarkers information updated
- 08 Apr 2013 New trial record